Related Experiment Video

Updated: Dec 15, 2025

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
06:38

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

30.7K

Macrophages, PPARs, and Cancer

Jo A Van Ginderachter1, Kiavash Movahedi, Jan Van den Bossche

  • 1Laboratory of Cellular and Molecular Immunology, Department of Molecular and Cellular Interactions, VIB, 1050 Brussels, Belgium.

PPAR Research
|July 11, 2008
PubMed

Insights

Peroxisome proliferator-activated receptors (PPARs) regulate immune cells, potentially inhibiting early cancer by targeting pro-inflammatory M1 macrophages. However, their use in established tumors requires caution due to diverse macrophage roles.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Mononuclear phagocytes act as immune system regulators, balancing pro- and anti-inflammatory responses.
  • Macrophages differentiate into M1 (pro-inflammatory) or M2 (anti-inflammatory) subsets based on stimuli.
  • Peroxisome proliferator-activated receptors (PPARs) expression is linked to macrophage polarization, generally opposing M1 and promoting M2 phenotypes.

Purpose of the Study:

  • To explore the role of PPARs in macrophage polarization within the context of cancer.
  • To evaluate the potential of PPAR agonists as chemopreventive agents against inflammation-driven cancers.
  • To assess the challenges and considerations for using PPAR agonists in established tumors.

Main Methods:

  • Review of existing knowledge on macrophage polarization and PPAR expression.
  • Analysis of the impact of M1 and M2 macrophage phenotypes in cancer initiation and progression.
  • Consideration of the therapeutic implications of PPAR agonists in different cancer stages.

Main Results:

  • M1 macrophages are implicated in initiating inflammation-driven cancers.
  • PPAR agonists show potential for inhibiting early tumorigenesis by antagonizing M1 macrophages.
  • The diverse macrophage phenotypes in established tumors complicate the predictable outcome of PPAR agonism.

Conclusions:

  • Current knowledge supports clinical evaluation of PPAR ligands for chemoprevention in chronic inflammation-associated cancers.
  • Caution is advised against the indiscriminate use of PPAR agonists as cancer therapeutics due to complex macrophage roles in established tumors.

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.9K
In Vitro Assay to Study Tumor-macrophage Interaction08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

7.9K

Related Concept Videos

Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
51.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K